SCNI: Rega marang dodolan Scinai

Simbol lan logo merek Scinai (SCNI)

In-house GMP manufacturing minimizes the need for contractors, which supports the price-to-sales multiple. The value 0.20 captures the magnitude of this parameter. The financial stability of Scinai Immunotherapeutics (SCNI) relies on grants and the success of nanobody testing. Patent protection for immunotherapy developments creates growth potential that will be realized upon the completion of clinical trials.

Scinai Immunotherapeutics Ltd. (SCNI): Multiplikator P/S saka 18.08.2024 nganti 16.11.2026

Rincian metrik lan analitis perusahaan Scinai Immunotherapeutics Ltd. (SCNI)

Analisis umum perusahaan:SCNI Scinai Immunotherapeutics Ltd.
Barang utama scinai.com

Scinai Immunotherapeutics focuses on developing innovative nano-antibodies to combat autoimmune pathologies and viral infections. By analyzing the current P/S ratio, an investor assesses the company's market value relative to its annual revenue, which helps identify whether the asset is overbought or if its commercial potential is undervalued against the backdrop of expected clinical trial results and the volume of secured grant funding.

Perusahaan pesaing

argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Pharma - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL: Multiplikator P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Intrexon|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|Rasio rega marang pendapatan UPB (Upstream Bio Corp)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Koefisien rega marang pendapatan immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator P/S|Kapitalisasi marang pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang pendapatan SVRA|Kapitalisasi marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator P/S ANAB|ATXS - Rega marang dodolan|Rasio rega marang pendapatan enGene Corp ENGN|Koefisien rega marang pendapatan RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|Rega marang dodolan Tiziana Life Sciences Ltd. (TLSA)|Kapitalisasi marang pendapatan CABA|Ventyx Biosciences (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELDN (eledon.com)|AGEN - Kapitalisasi marang pendapatan|CLYM - Rasio rega marang pendapatan|Rasio rega marang dodolan ZURA|ATYR: Multiplikator P/S|Adagene Corp (ADAG) - Multiplikator P/S|Kapitalisasi marang pendapatan IMA|Shattuck Labs, Inc. - Rasio rega marang dodolan|Rasio rega marang pendapatan Equillium Inc (EQ)|Multiplikator P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang pendapatan Immunic, Inc. IMUX|Multiplikator P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang pendapatan|XFOR: Rasio rega marang pendapatan|ACET: Multiplikator P/S|CELU - Koefisien rega marang pendapatan|Rasio rega marang pendapatan inmunebio.com|Rasio kapitalisasi marang pendapatan BRNS (barinthusbio.com)|Multiplikator P/S KZR|Multiplikator P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator P/S AKTX (Akari Therapeutics, Plc)|Multiplikator P/S enlivex.com ENLV|QTTB: Kapitalisasi marang pendapatan|GOVX - Multiplikator P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang pendapatan|IBIO - Koefisien rega marang pendapatan|Rasio rega marang pendapatan carismatx.com|XTLB: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan aptevotherapeutics.com APVO|AIM - Kapitalisasi marang pendapatan|Aditxt - Multiplikator P/S|Koefisien rega marang pendapatan GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang pendapatan|Rega marang dodolan reshapelifesciences.com (HIND)|Rasio rega marang pendapatan Revelation Bio|Rega marang dodolan Indaptus Therapeutics, Inc. INDP|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S